DEGAPT

Degarelix is used for the treatment of advanced prostate cancer. It is a type of gonadotropin-releasing hormone (GnRH) receptor antagonist, which works by blocking the action of GnRH in the body. GnRH is a hormone that stimulates the production of testosterone in the testicles, and testosterone is known to promote the growth and spread of prostate cancer.